Cor Vasa 2020, 62(1):21-28 | DOI: 10.33678/cor.2019.090

Development, effectiveness, and current possibilities in prenatal detection of congenital heart defects

Jan Pavlíčeka,b, Alicja Piegzovác, Eva Kláskovád, Sabina Kaprálovád, Alžběta Palátovád, Richard Špačekd, Tomáš Gruszkaa
a Department of Pediatrics and Prenatal Cardiology, University Hospital Ostrava, Ostrava
b Biomedical Research Center, University Hospital Hradec Králové, Hradec Králové
c Department of Obstetrics and Gynecology, University Hospital Ostrava, Ostrava
d Department of Pediatrics, Palacky University Hospital, Palacky University, Olomouc

Aim: To study the development and effectiveness of prenatal diagnostics for congenital heart defects (CHDs). To monitor the overall incidence of CHDs and the level of detection for individual types of fetal defects.

Methods: This retrospective cohort study retrieved data on ultrasound examinations of the fetal heart (fetal echocardiography), conducted by a gynecologist or pediatric cardiologist, and postnatal standardized examinations, conducted by a pediatric cardiologist, between 2011 and 2018. A pediatric cardiologist was present at all fetal autopsies and provided precise descriptions of the heart defect. All fetuses and newborns with severe pathologies were included to identify associated genetic and extracardiac pathologies.

Results: During the 8-year monitoring period, a total of 351 cases of severe heart defects were diagnosed in a population of 90,880 live births (3.9/1 000). CHDs manifested as an isolated anomaly in 72% of cases (252/351). In total, 66% of CHDs (230/351) were detected prenatally and 34% (121/351) of CHDs remained undetected until after birth. Screening effectiveness gradually improved over time; among the severe CHDs, 57% and 80% were detected prenatally in 2011 and 2018, respectively. Among all CHDs, the highest prenatal detection rates (80-100%) were observed for pathologies that affected ventricular morphology. In the group of prenatally diagnosed CHDs, 47% (109/230) of families decided to terminate the pregnancy, 5% (10/230) of fetuses died intrauterine, and 48% (111/230) of families continued the pregnancy.

Conclusion: CHDs mostly occurred as an isolated anomaly. The most severe CHDs were detected prenatally. We found that prenatal detection of CHDs was highly effective and gradually improved over time. The highest detection rate was for defects in the four-chamber projection. The participation of a pediatric cardiologist in fetal screening appeared to be necessary for determining the final diagnostics and for counseling the affected family.

Keywords: Congenital heart defect, Fetal echocardiography, Intrauterine death, Screening, Termination of pregnancy

Received: August 15, 2019; Revised: December 8, 2019; Accepted: December 20, 2019; Published: February 28, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pavlíček J, Piegzová A, Klásková E, Kaprálová S, Palátová A, Špaček R, Gruszka T. Development, effectiveness, and current possibilities in prenatal detection of congenital heart defects. Cor Vasa. 2020;62(1):21-28. doi: 10.33678/cor.2019.090.
Download citation

References

  1. van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide. J Am Coll Cardiol 2011;58:2241-2247. Go to original source... Go to PubMed...
  2. Chaloupecký V. Dětská kardiologie. Praha: Galén, 2006:119.
  3. Zhu RY, Gui YH, Li LC, et al. Fetal echocardiography in diagnosing congenital heart disease prenatally: a multicenter clinical study. Chinese Journal of Pediatrics 2006;44:764-769.
  4. Simpson JM. Impact of fetal echocardiography. Ann Pediatr Cardiol 2009;2:41-50. Go to original source... Go to PubMed...
  5. International Society of Ultrasound in Obstetrics & Gynecology. Cardiac screening examination of the fetus: guidelines for performing the 'basic' and 'extended basic' cardiac scan. Ultrasound Obst Gyn 2006;27:107-111. Go to original source... Go to PubMed...
  6. Marek J, Tomek V, Škovránek J, et al. Prenatal ultrasound screening of congenital heart disease in an unselected national population: a 21- year experience. Heart 2011;97:124-130. Go to original source... Go to PubMed...
  7. Jicinska H, Vlasin P, Jicinsky M, et al. Does First-Trimester Screening Modify the Natural History of Congenital Heart Disease? Circulation 2017;135:1045-1055. Go to original source... Go to PubMed...
  8. Fahed AC, Gelb BD, Seidman JG, Seidman CE. Genetics of Congenital Heart Disease. Circ Res 2013;112:707-720. Go to original source... Go to PubMed...
  9. Sípek A, Gregor V, Sípek A Jr, et al. Incidence of congenital heart defects in the Czech Republic - current data. Ceska Gynekol 2010;75:221-242.
  10. Yu ZB, Han SP, Guo XR. Meta-analysis of the value of fetal echocardiography for the prenatal diagnosis of congenital heart disease. Chin J Evid Based Pediatr 2009;4:330-339.
  11. Co-Vu J, Ivsic T. Fetal Echocardiography to Diagnose Fetal Heart Disease. Neoreviews 2012;13:e590-e604. Go to original source...
  12. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-1900. Go to original source... Go to PubMed...
  13. Tegnander E, Williams O, Johansen SJ, et al. Prenatal detection of heart defects in a non-selected population of 30 149 fetuses-detection rates and outcome. Ultrasound Obstet Gynecol 2006;27:252-265. Go to original source... Go to PubMed...
  14. Šamánek M, Slavík Z, Zbořilová B, et al. Prevalence, treatment, and outcome of heart disease in live-born children: A prospective analysis of 91,823 live born children. Pediat Cardiol 1989;10:205-211. Go to original source... Go to PubMed...
  15. Khoshnood B, De Vigan C, Vodovar V, et al. Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, 1983-2000: a population-based evaluation. Pediatrics 2005;115:95-101. Go to original source... Go to PubMed...
  16. Lytzen R, Vejlstrup N, Bjerre J, et al. Live-born major congenital heart disease in Denmark: incidence, detection rate, and termination of pregnancy rate from 1996 to 2013. JAMA Cardiol 2018;3:829-837. Go to original source... Go to PubMed...
  17. Tomek V, Marek J, Jíčínská, Škovránek J. Fetal cardiology in the Czech Republic: Current management of prenatally diagnosed congenital heart disease and arrhythmias. Physiol Res 2009;58(Suppl. 2):159-166. Go to original source...
  18. Jičínská H. Prenatální kardiologie v České republice. Čes-slov Pediat 2010;65:623-625.
  19. Tomek V, Gilík J, Jičínská H, et al. Prenatální detekce srdečních vad a její důsledky. Čes-slov Pediat 2018;73:284-290.
  20. Comas Gabriel C, Galindo A, Martinez JM, et al. Early prenatal diagnosis of major cardiac anomalies in a high risk population. Prenatal Diag 2002;22:586-593. Go to original source... Go to PubMed...
  21. Carvalho JS. Screening for heart defects in the first trimester of pregnancy: food for thought. Ultrasound Obst Gyn 2010;36:658-660. Go to original source... Go to PubMed...
  22. Campbell S, Allan L, Benacerraf B, et al. Isolated major congenital heart disease. Ultrasound Obst Gyn 2001;17:370-379. Go to original source... Go to PubMed...
  23. ACOG Committee on Practice Bulletins. AGOG practice bulletin No 58. Ultrasonography in pregnancy. Obstet Gynecol 2004;58:1449-1458. Go to original source... Go to PubMed...
  24. Bellotti M, Fesslova V, De Gasperi C, et al. Reliability of the first trimester cardiac scan by ultrasound trained obstetricians with high frequency transabdominal probes in fetuses with increased nuchal translucency. Ultrasound Obst Gyn 2010;36:272-278. Go to original source... Go to PubMed...
  25. Gómez O, Martinez JM. Ventricular Septal Defect. In: Obstetric Imaging: Fetal Diagnosis and Care (Second Edition) 2018;356-360e1. Go to original source...
  26. Jaeggi ET, Sholler GF, Jones OD, Cooper SG. Comparative analysis of pattern, management and outcome of pre- versus postnatallydiagnosed major congenital heart disease: a population based study. Ultrasound Obst Gyn 2001;17:380-385. Go to original source... Go to PubMed...
  27. Ogge G, Gaglioti P, Maccanti S, et al. Prenatal screening for congenital heart disease with four chamber and outflow tract views: a multicenter study. Ultrasound Obst Gyn 2006;28:779-784. Go to original source... Go to PubMed...
  28. Chew C, Halliday JL, Riley MM, Penny DJ. Population based study of antenatal detection of congenital heart disease by ultrasound examination. Ultrasound Obst Gyn 2007;29:619-624. Go to original source... Go to PubMed...
  29. Allan L. Antenatal diagnosis of heart disease. Heart 2000;83:367. Go to original source... Go to PubMed...
  30. Carvalho JS, Mavrides E, Shinebourne EA, et al. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart 2002:88:387-391. Go to original source... Go to PubMed...
  31. Comstock CH. What to expect from routine midtrimester screening for congenital heart disease. Semin Perinatol 2000;24:331-342. Go to original source... Go to PubMed...
  32. Stoll C, Dott B, Alembik Y, De Geeter B. Evaluation and evolution during time of prenatal diagnosis of congenital heart diseases by routine fetal ultrasonographic examination. Ann Genet 2002;45:21-27. Go to original source... Go to PubMed...
  33. Chaoui R, McEwing R. Three cross sectional planes for fetal color Doppler echocardiography. Ultrasound Obst Gyn 2003;21:81-93. Go to original source... Go to PubMed...
  34. Gómez O, Soveral I, Bennasar M, et al. Accuracy of fetal echocardiography in the differential diagnosis between truncus arteriosus and pulmonary atresia with ventricular septal defect. Fetal Diagn Ther 2016;39:90-99. Go to original source... Go to PubMed...
  35. Blue GM, Kirk EP, Sholler GF, et al. Congenital heart disease: current knowledge about causes and inheritance. Med J Australia 2012;197:155-159. Go to original source... Go to PubMed...
  36. Tumanyan MR, Filaretova OV, Chechneva VV, et al. Repair of complete atrioventricular septal defect in infants with Down syndrome: outcomes and long-term results. Pediatr Cardiol 2015;36:71-75. Go to original source... Go to PubMed...
  37. Brick DH, Allan LD. Outcome of prenatally diagnosed congenital heart disease: an update. Pediatr Cardiol 2002;23:449-453. Go to original source... Go to PubMed...
  38. Muncke N, Jung C, Rüdiger H, et al. Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). Circulation 2003;108:2843-2850. Go to original source... Go to PubMed...
  39. De Luca A, Sarkozy A, Consoli F, et al. Familial transposition of the great arteries caused by multiple mutations in laterality genes. Heart 2010;96:673-677. Go to original source... Go to PubMed...
  40. Edwards JJ, Gelb BD. Genetics of congenital heart disease. Curr Opin Cardiol 2016;31:235-241. Go to original source... Go to PubMed...
  41. Chenni N, Lacroze V, Pouet C, et al. Fetal heart disease and interruption of pregnancy: factors influencing the parental decision-making process. Prenat Diagn 2012;32:168-172. Go to original source... Go to PubMed...
  42. Calderon J, Angeard N, Moutier S, et al. Impact of prenatal diagnosis on neurocognitive outcomes in children with transposition of great arteries. J Pediatr 2012;161:94-98. Go to original source... Go to PubMed...
  43. Landis BJ, Levey A, Levasseur SM, et al. Prenatal diagnosis of congenital heart disease and birth outcomes. Pediatr Cardiol 2013;34:597-605. Go to original source... Go to PubMed...
  44. Khoshnood B, Lelong N, Houyel L, et al. Impact of prenatal diagnosis on survival of newborns with four congenital heart defects: a prospective, population-based cohort study in France (the EPICARD Study). BMJ Open 2017;7:e018285. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.